Articles tagged with Respiratory Disorders
Researchers predict that personalized medicine interventions could generate significant healthcare gains, including a $607 billion reduction in heart disease incidence. However, weak incentives to develop these interventions hinder their adoption, and experts suggest reimbursement reform could strengthen manufacturers' incentives.
Scientists have discovered a new autoimmune syndrome characterized by severe lung disease and arthritis in early childhood. The disorder is caused by mutations in the COPA gene, which disrupts protein trafficking within cells, leading to cellular stress and an immune response. Researchers believe that targeting Th17 cells with drugs ma...
Research reveals FGFR1 amplification in 22.7% of small cell lung cancer tumors, implying applicability to non-small cell lung cancer treatments
A team of UC researchers will study the rare lung disease pulmonary alveolar microlithiasis, which causes 'lung stones' and reduces life expectancy by several decades. The grant will help them develop a mouse model to understand the cause of the disease and design trials for treatment.
The increasing use of asbestos in Asia poses a significant threat to public health, with the potential for widespread mesothelioma and lung cancer cases. Government and non-government groups must work together to improve recognition and diagnosis of asbestos-related lung diseases.
Researchers have created a disease signature for alpha-1 antitrypsin deficiency using induced pluripotent stem cells (iPSCs), which may lead to new treatments. The study found that liver cells derived from AAT deficient iPSCs are more sensitive to drugs that cause liver toxicity than normal cells.
Researchers have found a correlation between metabolic imbalance and increased risk of respiratory diseases in early childhood. Elevated concentrations of specific sugars, such as hexoses, were associated with elevated inflammatory immune parameters.
New connections in gene regulation have been discovered in normal lung cells that may contribute to lung tumor formation. The researchers found that the transcription factor Nkx2-1 regulates lung cell proliferation, tumor growth, and progression by binding to microRNAs.
A pulmonary rehabilitation programme will be assessed and implemented in Uganda, Tanzania, and Zambia to improve treatment and quality of life for patients with chronic lung disease. The study aims to reduce the burden on local communities and economies by developing an effective and inclusive programme.
A nationwide survey of 2200 French adults reveals significant knowledge gaps about lung cancer, including misconceptions about screening, treatment options, and prognosis. The study emphasizes the need for public education to address these gaps and improve outcomes.
As people live longer, soaring levels of chronic illness and diminished wellbeing threaten the quality of life of older people. Strategies are needed to prevent and manage chronic conditions through affordable healthcare and social environment changes.
The NIH has awarded $29 million to expand the Rare Diseases Clinical Research Network, a collaborative effort of physician scientists and patient advocacy groups. This funding will support clinical research and investigation of new treatments for patients with rare diseases, with a focus on improving diagnosis and treatment outcomes.
A meta-analysis of 70 studies found that fludeoxyglucose F18-PET combined with CT is less accurate for diagnosing lung cancer in areas with endemic infectious lung diseases. The pooled sensitivity was 89%, but specificity was lower (61%) compared to non-endemic regions (77%).
A study published in the Canadian Medical Association Journal found that South Asians in Canada have a higher prevalence of heart disease, with rates of death from coronary artery disease being 42% for men and 29% for women. The study also highlighted the need for standardized surveillance systems to monitor non-communicable diseases a...
The University of Michigan is developing a wearable vapor sensor that can detect airborne chemicals for continuous disease monitoring. The device has the potential to track conditions such as diabetes, high blood pressure, anemia, and lung disease.
Researchers found nine variants in the CFTR gene associated with pancreatitis, sinusitis, and male infertility, but leave the lungs unaffected. The study identifies mechanisms behind these conditions, paving the way for treatments and potential medications.
A team of researchers has identified six new gene loci associated with forced vital capacity, a volume parameter of lung function. The study suggests involvement of these genes in lung development and certain pulmonary diseases.
Researchers used breath analysis to detect lung cancer with a sensitivity comparable to PET scanning and a higher specificity, distinguishing patients with benign disease from those with early-stage cancer. The method shows promise as a non-invasive diagnostic tool, expediting treatment for patients with lung cancer.
Researchers found that intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells can prevent or treat bronchopulmonary dysplasia (BPD) in very preterm infants. The treatment also showed a lower incidence of retinopathy of prematurity requiring surgery.
The lung microbiome is a new frontier in pulmonary medicine, with research exploring the role of microorganisms in health and disease. The emerging field is leading to new ways of thinking about the lung and its diseases.
The American Thoracic Society Foundation and the American Lung Association are co-funding an $80,000 grant to study Hermansky-Pudlak syndrome, a rare inherited disease affecting the lungs. The research aims to understand HPS pulmonary fibrosis and explore potential treatments for common lung diseases like cystic fibrosis.
A study revealed RSV infection induces distinct global gene expression patterns in young children, identifying a 'biosignature' for diagnosis and disease severity assessment. The research also uncovered suppressed non-specific immune system genes and elevated inflammation genes in infants under 6 months.
The American Thoracic Society and European Respiratory Society have released a policy statement aiming to reduce health disparities in respiratory health. The statement emphasizes the disproportionate impact of respiratory diseases on socioeconomically disadvantaged groups, particularly children.
The National Institutes of Health has awarded a $5.9 million grant to the Geisel School of Medicine at Dartmouth for its Lung Biology Center of Biomedical Research Excellence. This funding supports cystic fibrosis research and translates basic science into clinical applications.
Researchers have developed a cheap and non-invasive breath test to diagnose lung cancer, which has been shown to correctly identify lung cancer patients with high sensitivity. The technique uses an electronic nose to detect volatile organic compounds in exhaled breath samples.
Young people have difficulty learning from bad news, but are more likely to adapt to good news; campaigns targeting them should focus on positive benefits instead of risks
At high altitudes, pulmonary hypertension develops as a normal adaptive response but can become life-threatening if exaggerated. Research highlights the need for targeted drug therapy, with potential new directions emerging in understanding epigenetic mechanisms and their role in disease
Men with restless legs syndrome (RLS) have a nearly 40% increased risk of death compared to men without RLS. The study also found that the association dropped only slightly after adjusting for factors such as body mass index and lifestyle, indicating that RLS may lead to higher mortality rates independently of other known risk factors.
A common genetic variant of the MUC5B gene is linked to an increased risk of interstitial lung disease and symptoms such as shortness of breath and cough. The study suggests that this variant may be a key indicator for predicting individuals at risk for pulmonary fibrosis, potentially paving the way for prevention efforts.
A genome-wide association study identified a novel genetic locus linked to both the onset and mortality of idiopathic pulmonary fibrosis. The study found that a variant in the TOLLIP gene was associated with an increased risk of death, suggesting an abnormal immune response may be central to the disease.
A randomized controlled trial found that erythromycin significantly reduced pulmonary exacerbations and improved symptoms in patients with non-CF bronchiectasis, but also increased macrolide resistance. The study suggests that low-dose erythromycin may be beneficial for treatment of respiratory disorder in certain patient populations.
Research suggests a significant link between reduced biomass smoke pollution and decreased all-cause mortality, particularly among men. A study in Tasmania found that interventions to reduce wood heater use led to a 40% decrease in particulate air pollution and a 22.8% reduction in respiratory mortality for males alone.
Endothelial cells, not muscle cells on the outside of blood vessels, are responsible for sensing low oxygen levels and triggering pulmonary hypertension. Researchers at St. Michael's Hospital found that blocking communication between endothelial cells and smooth muscle cells could potentially prevent right heart failure.
Researchers found that levels of IL-6 and IL-12 were higher among patients with sarcoidosis compared to controls. Mold/fungi levels in the home also showed a significant relation to β-glucan levels. The study supports the hypothesis that exposure to fungi increases the risk of sarcoidosis.
Researchers identified a genetic signature that distinguishes patients with complicated sarcoidosis from those with a more benign form. The 20-gene pattern can be used to identify patients at risk of serious complications and potentially life-threatening disease.
The study found an increase in non-smokers developing lung cancer, particularly women, and a shift towards adenocarcinoma. Researchers attributed this change to improved diagnostic techniques and management of lung cancer.
New global benchmarks for lung function have been established, providing a consistent measurement across the entire life span. These charts will help healthcare professionals better understand lung disease progression and raise awareness of its impact on people worldwide.
Researchers have identified a promising new treatment for non-cystic fibrosis bronchiectasis, which reduces the frequency of exacerbations and increases time to first exacerbation. The treatment, azithromycin, has shown benefits persisting for six months after completion, offering a new option for patients with this debilitating disease.
A recent study found that only 19% of seniors with lung disease quit smoking within two years, while regular exercise improved were rare. The research suggests intensive efforts are needed to help seniors make lifestyle changes after a chronic diagnosis.
Research shows that lung transplant patients receiving organs from smokers tend to survive longer than those waiting on the list, with significant benefits for patients with septic lung disease and fibrosis. The UK's current selection policy of including both smoking and non-smoking donors improves survival rates and should be continued.
A revised definition of acute respiratory distress syndrome (ARDS) includes a distinction between severe and less advanced cases, allowing for earlier detection and intervention. The new guidelines are based on evidence from over 4,000 patients and have the potential to improve treatment outcomes.
Researchers analyzed four studies and found that regular follow-up reduces crisis-driven health episodes. While no preferred method was determined, the authors recommend guidelines for initial specialist appointments and protocol-driven follow-up led by a lung cancer clinical nurse specialist.
Experts urge policymakers to introduce changes to ensure safe and clean air in Europe. The European Respiratory Society has devised 10 principles for clean air, calling for significant reductions in fine particles and ozone, as well as policy changes to reduce ultrafine particle emissions from motor vehicles.
A new study has found that the lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis. LCI was elevated in children with CF, especially in those with airway inflammation and Pseudomonas aeruginosa infection.
A study published in the Journal of Bone and Joint Surgery found that comorbidities such as high blood pressure, fluid and electrolyte disorders, and congestive heart failure significantly raise hospitalization costs and length of stay for hip fracture patients. Recent weight loss or malnutrition also had a major impact on hospitalizat...
A large cohort study found that statin use was associated with an increased risk of interstitial lung abnormalities (ILA) in smokers, with a 60% higher odds of ILA compared to non-statins users. Statins also exacerbated lung fibrosis in mice and enhanced Nlrp3-inflammasome activation.
A panel of blood proteins can predict patient survival in idiopathic pulmonary fibrosis, guiding treatment plans and identifying those in urgent need of a lung transplant. The biomarker panel has predictive power that may also help design more effective research trials.
A new analysis found that coughing is more common in patients with advanced idiopathic pulmonary fibrosis and predicts rapid disease progression. The study suggests that patients who cough may have a worse prognosis, benefiting from closer monitoring and aggressive treatments.
Researchers have discovered a protein called ubiquitin ligase Nedd4L as a new regulator of cystic fibrosis. Mice lacking Nedd4L in the lung developed cystic fibrosis-like disease, highlighting a promising therapeutic target. Enhancing Nedd4L function or inhibiting ENaC may alleviate symptoms of the disease.
A new study from Nationwide Children's Hospital helps clarify the definition of gastroesophageal reflux disease (GERD) in neonates. The research finds that symptoms can occur with acid, non-acid, gas, liquid, or mixed events, making treatment strategies based on modifying gastric acidity alone ineffective.
Researchers at Case Western Reserve University have developed an artificial lung that uses air instead of pure oxygen, achieving efficiencies comparable to the genuine organ. The device is a significant step towards creating easily portable and implantable lungs, with potential use in humans within a decade.
A nine-year study found that high fiber intake was associated with a significantly reduced risk of total death, cardiovascular, infectious, and respiratory diseases in both men and women. Dietary fiber from whole plant foods, such as grains, was particularly beneficial.
Researchers found that N-acetylcysteine reduces the size and activity of von Willebrand factor multimers in human plasma and mice, offering a potential rapid treatment for patients with TTP. The study suggests that this approach could be effective in reducing complications associated with current treatments.
People with sleep apnoea or obesity-related respiratory difficulties incur twice as high medicine and hospital costs as healthy control subjects, with unemployment rates 30% higher. Violent snoring costs €705 per person, while sleep apnoea costs €3860 and obesity-related respiratory difficulties cost €11,320.
Global neglect of chronic diseases is a pressing issue, with low-cost solutions available for prevention. The authors recommend reframing the debate to emphasize societal determinants and mobilizing resources through cooperative approaches.
Researchers have developed a diagnostic blood test that can identify lymphangioleiomyomatosis (LAM), a rare but serious lung disease affecting women. The test analyzes serum VEGF-D levels, showing high accuracy in diagnosing LAM, and may help screen for the disease in women with Tuberous Sclerosis Complex.
Researchers found that genetic mutations affecting cilia function may predispose older individuals to pulmonary diseases. A simple nitric oxide testing can identify patients at risk of abnormal ciliary function.
Researchers at the University of Pittsburgh School of Medicine have identified a molecular mechanism for idiopathic pulmonary fibrosis (IPF), a chronic and usually lethal disease. The study found that microRNA changes contribute to IPF, with let-7d being significantly reduced in affected tissues.
A new experimental model using pigs with a CF-causing gene mutation has provided valuable insights into the development of lung disease in people with cystic fibrosis. The study's findings suggest that infection precedes inflammation in CF lungs, supporting early and aggressive treatment to delay or prevent lung disease.
Research published in Journal of Thoracic Oncology investigates the effectiveness of surgery as a standalone treatment for stage I small cell lung cancer. The study found three- and five-year survival rates of 58.1% and 50.3%, respectively, for patients who underwent lobectomies without radiotherapy.